Merck & Co Inc (NYSE:MRK)
| 82.96 Delayed Data As of Sep 25 |  -0.19 / -0.23%Today’s Change | 65.25 Today|||52-Week Range 92.64 | -8.79% Year-to-Date |
Latest MRK News | Press Releases
Today’s Trading
| Previous close | 83.15 |
| Today’s open | 82.15 |
| Day’s range | 81.80 - 83.24 |
| Volume | 6,614,914 |
| Average volume (3 months) | 8,964,105 |
| Market cap | $210.3B |
Data as of 4:00pm ET, 09/25/2020
Growth & Valuation
| Earnings growth (last year) | +64.36% |
| Earnings growth (this year) | +10.16% |
| Earnings growth (next 5 years) | +7.25% |
| Revenue growth (last year) | +9.75% |
| P/E ratio | 20.2 |
| Price/Sales | 5.04 |
| Price/Book | 8.15 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer | +0.29 | +0.81% |
| NVSNovartis | +0.81 | +0.94% |
| ABBVAbbVie | +0.31 | +0.36% |
| AZNAstraZeneca | +1.37 | +2.53% |
Data as of 5:19pm ET, 09/25/2020
Financials
| Next reporting date | October 27, 2020 |
| EPS forecast (this quarter) | $1.43 |
| Annual revenue (last year) | $46.6B |
| Annual profit (last year) | $9.8B |
| Net profit margin | 21.13% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Kenilworth, New Jersey |
Forecasts
